Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Yongchun HuangJiangxi Provincial Key Laboratory of Biodiversity Conservation and Resource Utilization, College of Life Science, Jiangxi Normal University, Nanchang 330022, China.
Xinyuan LiJiangxi Provincial Key Laboratory of Biodiversity Conservation and Resource Utilization, College of Life Science, Jiangxi Normal University, Nanchang 330022, China.
Liangfang DaiJiangxi Provincial Key Laboratory of Biodiversity Conservation and Resource Utilization, College of Life Science, Jiangxi Normal University, Nanchang 330022, China.
Malong ChengJiangxi Provincial Key Laboratory of Biodiversity Conservation and Resource Utilization, College of Life Science, Jiangxi Normal University, Nanchang 330022, China.
Linlin ZhaoJiangxi Provincial Key Laboratory of Biodiversity Conservation and Resource Utilization, College of Life Science, Jiangxi Normal University, Nanchang 330022, China.
Yu ShenJiangxi Provincial Key Laboratory of Biodiversity Conservation and Resource Utilization, College of Life Science, Jiangxi Normal University, Nanchang 330022, China.
Jiankun XieJiangxi Provincial Key Laboratory of Biodiversity Conservation and Resource Utilization, College of Life Science, Jiangxi Normal University, Nanchang 330022, China.
Xiangdong LuoJiangxi Provincial Key Laboratory of Biodiversity Conservation and Resource Utilization, College of Life Science, Jiangxi Normal University, Nanchang 330022, China.ORCID 0000-0001-6466-7144
Funding
Major Academic and Technical Leader Training Project of Jiangxi Province 20204BCJ22024National Natural Science Foundation of China 32060074Natural Science Foundation of Jiangxi Province, China 20232ACB2050009
6 · The paper itself
Abstract
Huperzine A is a preferred treatment option for Alzheimer's disease.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.